CRIS Cancer Foundation and the ICR are offering 2-3 year fellowships to support the development of outstanding early ...

The Oncogenetics group have three sub-groups working alongside each other: the lab group of scientists and clinical fellows, the data group of scientists and administrators and the clinical group of ...

"Search" is our twice-yearly newsletter to supporters. In our latest edition of Spring Search issue, we look at the latest research news including how our scientists are developing improved breast ...

The Institute of Cancer Research, London, strongly welcomes the decision by NICE to recommend the targeted breast cancer drug, capivasertib, in combination with fulvestrant, for treating the most ...

The Breast Cancer Now Toby Robins Research Centre at the ICR receives funding from the charity Breast Cancer Now, and was opened in 1999 by Breast Cancer Now's Patron, HRH The Prince of Wales. The ...

A spit test, where a sample can be collected at home, is more accurate at identifying future risk of prostate cancer for some men than the current standard PSA blood test, a new study reports. Results ...

The ICR, in collaboration with The Royal Marsden NHS Foundation Trust, has now taken delivery of the latest genome sequencing device, the NovaSeq X Plus. In this blog post, Mark Jones speaks with ...

Breast cancer remains a leading cause of cancer-related deaths globally, with triple-negative breast cancer (TNBC) presenting particular therapeutic challenges due to its aggressive nature and limited ...

Nadia, 28, is running her third London Landmarks half marathon for the ICR. She explains why supporting our vital research is so important to her. When I was 18, I was living in South Africa and was ...